Search
My Stocks
SGX
Google
Yahoo
News
TradingView
IX BIOPHARMA LTD. (42C)
SGD 0.03
+6.67% +0.00
Portfolio
Watchlist
Divs
Anns
Trans
Notes
Articles
All
Financial
Buy Back
Insider Trading
2020-04-28
General Announcement::Press Release: iX Biopharma inks agreement with Cannatrek to supply Xativa to the Australian market
2020-04-26
General Announcement::Press Release: Licensing, supply and distribution of Wafesil, sublingual sildenafil wafer, in China
2020-04-13
General Announcement::ENTITY EXPANDS NUTRACEUTICAL BUSINESS IN CHINA WITH LAUNCH OF SECOND FLAGSHIP E-COMMERCE STORE
2020-04-06
General Announcement::PRESS RELEASE - ENTITY COMMENCES SALE OF NUTRACEUTICALS TO CONSUMERS IN CHINA
2020-03-02
General Announcement::CESSATION OF QUARTERLY REPORTING
2020-02-11
Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results
2020-01-30
General Announcement::iX Biopharma Ltd. - Presentation for Phillip Securities - Jan 2020
2020-01-17
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2019-12-10
General Announcement::PRESS RELEASE - END-OF-PHASE 2 MEETING WITH THE U.S. FDA REGARDING WAFERMINE
2019-12-05
General Announcement::IX BIOPHARMA SECURES AUSTRALIAN CANNABIS MANUFACTURE LICENCE
2019-11-27
General Announcement::CHANGE IN COMPOSITION OF THE BOARD AND BOARD COMMITTEES OF THE COMPANY
2019-11-27
Change - Announcement of Appointment::Appointment of Non-Executive Independent Director
2019-11-26
Annual Reports and Related Documents::
2019-11-15
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2019-11-15
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2019-11-05
Financial Statements and Related Announcement::First Quarter Results
2019-10-22
General Announcement::IX BIOPHARMA SECURES INDIA PATENT FOR ITS WAFERIX DRUG DELIVERY TECHNOLOGY
2019-10-18
REPL::Annual General Meeting::Voluntary
2019-09-25
Annual Reports and Related Documents::
2019-09-25
Annual General Meeting::Voluntary
2019-08-23
Financial Statements and Related Announcement::Full Yearly Results
2019-06-21
Annual Reports and Related Documents::
2019-05-27
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities
2019-05-24
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director in respect of Interests in Securities
2019-05-21
General Announcement::FIRST SUBLINGUAL KETAMINE DRUG FOR TREATMENT OF ACUTE PAIN TO BE EVALUATED IN EOP2 MEETING WITH FDA
2019-05-09
Financial Statements and Related Announcement::Third Quarter Results
2019-03-29
Change - Announcement of Appointment::Appointment of Chief Operating Officer
2019-03-17
Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS
2019-02-17
Asset Acquisitions and Disposals::PROPOSED DISPOSAL OF LABORATORY TESTING BUSINESS
2019-02-11
Financial Statements and Related Announcement::Second Quarter and/ or Half Yearly Results
2018-12-14
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2018-11-30
REPL::Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2018-11-16
Employee Stock Option/ Share Scheme::GRANT OF SHARE AWARDS PURSUANT TO iX PERFORMANCE SHARE PLAN
2018-11-16
Employee Stock Option/ Share Scheme::ISSUE AND ALLOTMENT OF NEW SHARES PURSUANT TO IX PERFORMANCE SHARE PLAN
2018-11-12
General Announcement::CHANGES IN THE COMPOSITION OF THE BOARD AND REMUNERATION COMMITTEE
2018-11-12
Financial Statements and Related Announcement::First Quarter Results
2018-11-06
REPL::General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
2018-11-05
General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
2018-10-19
Change - Announcement of Cessation::Retirement of Lead Independent Director
2018-10-19
REPL::Annual General Meeting::Voluntary
2018-09-26
Annual Reports and Related Documents::
2018-09-26
Annual General Meeting::Voluntary
2018-09-21
General Announcement::UPDATE ANNOUNCEMENT ON PROPOSED SILDENAFIL RECLASSIFICATION
2018-09-05
General Announcement::IX BIOPHARMA REPORTS POSITIVE RESULTS FROM WAFERMINE PHASE 2 MULTI-DOSE CLINICAL EFFICACY TRIAL
2018-08-27
Financial Statements and Related Announcement::Full Yearly Results
2018-08-06
General Announcement::APPROVAL OF FIRST CAPSULE SILDENAFIL DRUG FOR TREATMENT OF MALE ERECTILE DYSFUNCTION IN AUSTRALIA
2018-06-25
General Announcement::CHANGE IN USE OF IPO PROCEEDS
2018-06-19
General Announcement::IX BIOPHARMA OBTAINS APPROVAL & REGISTRATION OF WAFESIL FOR TREATMENT OF MALE ERECTILE DYSFUNCTION
2018-06-12
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)::Notification Form for Substantial Shareholder in respect of Interests in Securities
2018-05-09
Financial Statements and Related Announcement::Third Quarter Results
«
Previous
2
3
4
5
6
»
Next
© 2024 Dividends.sg /
More Countries
© Owned by Little White Pte. Ltd.